J Clin Transl Hepatol. 2016 Mar 28;4(1):54-65. doi: 10.14218/JCTH.2015.00041. Epub 2016 Mar 15.
Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation.
Journal of clinical and translational hepatology
Rakhi Maiwall, Manoj Kumar
Affiliations
Affiliations
- Hepatology and Liver Transplantation, Institute of Liver and Biliary Sciences, New Delhi, India.
PMID: 27047773
PMCID: PMC4807144 DOI: 10.14218/JCTH.2015.00041
Abstract
Chronic hepatitis B is a global health problem that leads to development of various complications, such as cirrhosis, liver cancer, and liver failure requiring liver transplantation. The recurrence of hepatitis B virus (HBV) post-liver transplantation is a major cause of allograft dysfunction, cirrhosis of the allograft, and graft failure. Patients with high viral load at the time of transplantation, hepatitis B e antigen (HBeAg) positivity, or those with a history of anti-viral drug resistance are considered as high-risk for recurrent HBV post-liver transplantation, while patients with low viral load, including HBeAg negative status, acute liver failure, and hepatitis D virus (HDV) co-infection are considered to be at low-risk for recurrent HBV post-liver transplantation. Antivirals for patients awaiting liver transplantation(LT) cause suppression of HBV replication and reduce the risk of recurrent HBV infection of the allograft and, therefore, all HBV patients with decompensated cirrhosis should be treated with potent antivirals with high genetic barrier to resistance (entecavir or tenofovir) prior to liver transplantation. Prevention of post-liver transplantation recurrence should be done using a combination of hepatitis B immunoglobulin (HBIG) and antivirals in patients at high risk of recurrence. Low dose HBIG, HBIG-free protocols, and monoprophylaxis with high potency antivirals can still be considered in patients at low risk of recurrence. Even, marginal grafts from anti-HBc positive donors can be safely used in hepatitis B surface antigen (HBsAg) negative, preferably in anti-hepatitis B core (HBc)/anti-hepatitis B surface (HBs) positive recipients. In this article, we aim to review the mechanisms and risk factors of HBV recurrence post-LT in addition to the various treatment strategies proposed for the prevention of recurrent HBV infection.
Keywords: Hepatitis B; Liver transplant; Recurrent
References
- J Hepatol. 2001 Jun;34(6):903-10 - PubMed
- Virus Res. 2007 Jun;126(1-2):245-9 - PubMed
- Liver Transpl. 2006 Feb;12 (2):253-8 - PubMed
- Gastroenterology. 2011 Oct;141(4):1212-9 - PubMed
- Hepatology. 1996 Dec;24(6):1327-33 - PubMed
- J Hepatol. 2003 Jun;38(6):811-7 - PubMed
- J Hepatol. 1999 Apr;30(4):715-21 - PubMed
- Int J Inflam. 2014;2014:814760 - PubMed
- Gastroenterology. 2005 Jul;129(1):234-45 - PubMed
- Antivir Ther. 2011;16(4):479-87 - PubMed
- Hepatology. 2003 Oct;38(4):811-9 - PubMed
- J Hepatol. 2010 Feb;52(2):272-9 - PubMed
- Int J Mol Sci. 2015 Jul 30;16(8):17494-513 - PubMed
- Hepatology. 2002 Jun;35(6):1528-35 - PubMed
- J Biol Chem. 2015 Feb 27;290(9):5673-84 - PubMed
- Am J Pathol. 1986 Oct;125(1):161-72 - PubMed
- Dig Dis Sci. 2010 Feb;55(2):505-9 - PubMed
- Transplantation. 2009 Jan 15;87(1):103-11 - PubMed
- J Med Virol. 2013 Nov;85(11):1900-6 - PubMed
- Nat Med. 1996 Oct;2(10):1104-8 - PubMed
- Clin Transplant. 2011 Jul-Aug;25(4):517-22 - PubMed
- Transpl Infect Dis. 2015 Jun;17(3):329-33 - PubMed
- Gastroenterology. 1999 Dec;117(6):1386-96 - PubMed
- Liver Transpl. 2007 Mar;13(3):367-73 - PubMed
- Liver. 1999 Jun;19(3):177-82 - PubMed
- Liver Transpl. 2013 Jun;19(6):594-601 - PubMed
- Hepatology. 2000 Feb;31(2):496-501 - PubMed
- J Hepatol. 2012 May;56(5):1189-97 - PubMed
- J Virol. 2003 Aug;77(16):8882-92 - PubMed
- PLoS One. 2013;8(3):e59611 - PubMed
- EMBO J. 2007 Sep 19;26(18):4160-7 - PubMed
- Elife. 2012 Nov 13;1:e00049 - PubMed
- Gut. 2010 Oct;59(10):1430-45 - PubMed
- Gastroenterology. 2013 Jun;144(7):1508-17, 1517.e1-10 - PubMed
- Gastroenterology. 2007 Mar;132(3):931-7 - PubMed
- Am J Gastroenterol. 2013 Jun;108(6):942-8 - PubMed
- Gastroenterology. 2010 Feb;138(2):682-93, 693.e1-4 - PubMed
- Transplant Proc. 2002 Jun;34(4):1252-4 - PubMed
- Hepatol Int. 2016 Jan;10 (1):1-98 - PubMed
- Hepatology. 2008 Nov;48(5):1460-6 - PubMed
- Hepatology. 2000 Dec;32(6):1189-95 - PubMed
- Hepatol Int. 2011 Mar 25;5(4):918-926 - PubMed
- Intervirology. 2014;57(3-4):196-201 - PubMed
- Am J Transplant. 2013 Feb;13(2):353-62 - PubMed
- Liver Transpl. 2000 Nov;6(6):741-8 - PubMed
- Gastroenterology. 1988 Jan;94(1):151-6 - PubMed
- Liver Transpl. 2007 Mar;13(3):349-60 - PubMed
- Transpl Int. 2010 Nov;23(11):1105-12 - PubMed
- Transpl Infect Dis. 2012 Oct;14 (5):479-87 - PubMed
- J Hepatol. 2011 Sep;55(3):587-93 - PubMed
- Transplantation. 1996 May 15;61(9):1358-64 - PubMed
- Antimicrob Agents Chemother. 2012 Aug;56(8):4277-88 - PubMed
- Cochrane Database Syst Rev. 2010 Jul 07;(7):CD006005 - PubMed
- Transplant Proc. 2001 Nov-Dec;33(7-8):3637-8 - PubMed
- Gastroenterology. 1993 Jun;104(6):1818-21 - PubMed
- Ann Surg. 2001 Feb;233(2):276-81 - PubMed
- Mol Ther. 2013 May;21(5):973-85 - PubMed
- J Viral Hepat. 2005 Mar;12(2):212-5 - PubMed
- J Hepatol. 1999 Apr;30(4):706-14 - PubMed
- J Hepatol. 2009 Sep;51(3):581-92 - PubMed
- Hepatology. 2003 Jul;38(1):86-95 - PubMed
- Am J Transplant. 2011 Mar;11(3):511-7 - PubMed
- Liver Transpl. 2007 Mar;13(3):374-81 - PubMed
- Dig Dis Sci. 2007 Oct;52(10 ):2497-500 - PubMed
- Am J Transplant. 2010 Aug;10 (8):1823-33 - PubMed
- Hepatology. 2002 Jan;35(1):176-81 - PubMed
- J Med Virol. 1997 Jun;52(2):226-33 - PubMed
- Transplant Proc. 2004 Apr;36(3):535-8 - PubMed
- Nat Biotechnol. 2008 Mar;26(3):335-41 - PubMed
- Liver Transpl. 2006 Feb;12(2):316-9 - PubMed
- N Engl J Med. 1993 Dec 16;329(25):1842-7 - PubMed
- Liver Transpl. 2011 Oct;17 (10 ):1176-90 - PubMed
- Acta Med Okayama. 2014;68(1):53-6 - PubMed
- Liver Transpl. 2007 Jan;13(1):71-9 - PubMed
- Gastroenterology. 2014 Jul;147(1):48-64 - PubMed
- Transplantation. 2001 Oct 27;72 (8):1381-5 - PubMed
- Am J Transplant. 2013 Feb;13(2):348-52 - PubMed
- J Hepatol. 2013 May;58(5):861-7 - PubMed
- J Hepatol. 2014 Apr;60(4):723-31 - PubMed
- Liver Transpl. 2005 Apr;11(4):402-9 - PubMed
- J Viral Hepat. 2010 Feb 1;17(2):123-9 - PubMed
- Liver Transpl. 2013 Mar;19(3):268-74 - PubMed
- Clin Transplant. 2006 Mar-Apr;20(2):206-10 - PubMed
- Front Immunol. 2014 Jun 03;5:258 - PubMed
- Hepatology. 1998 Aug;28(2):585-9 - PubMed
- Hepatology. 2011 May;53(5):1494-503 - PubMed
- Transplantation. 1998 Feb 27;65(4):494-9 - PubMed
- Am J Pathol. 1990 Sep;137(3):667-76 - PubMed
- Hepatology. 1991 Apr;13(4):619-26 - PubMed
- J Gastroenterol. 2013 Dec;48(12 ):1401-10 - PubMed
- Transpl Int. 2009 Apr;22(4):387-94 - PubMed
- PLoS One. 2012;7(10 ):e47648 - PubMed
- Liver Transpl. 2013 Sep;19(9):1030-5 - PubMed
- Hepatology. 2001 Feb;33(2):424-32 - PubMed
- Liver Transpl. 2005 Oct;11(10 ):1228-34 - PubMed
- World J Gastroenterol. 2013 Dec 28;19(48):9189-97 - PubMed
- J Hepatol. 2001 Jun;34(6):895-902 - PubMed
- Gastroenterology. 2008 Jun;134(7):1890-9; quiz 2155 - PubMed
- J Infect Dis. 1999 Jul;180(1):15-26 - PubMed
- World J Gastroenterol. 2007 Jan 7;13(1):65-73 - PubMed
- Transplant Proc. 2006 Mar;38(2):579-83 - PubMed
- Transpl Infect Dis. 2015 Apr;17 (2):208-20 - PubMed
- J Virol. 2007 Apr;81(8):4215-25 - PubMed
- Transplantation. 2007 Sep 15;84(5):650-4 - PubMed
Publication Types